| Application no. and date | 11749612.5 (espacenet) (Federated) (European Patent Register), 20110729 | | Patent/reg. no. and date | DK/EP 2598526, 20180905 | | Publication date | 20130605 | | Priority no. and date | US 368799 P, 20100729, US 201161436184 P, 20110125, US 201161436178 P, 20110125, US 201161493966 P, 20110606, US 201161493967 P, 20110606 | | EP pub. no. and date |
EP 2598526 20130605 | | Effective date | | | Applicant/owner | Buzzard Pharmaceuticals AB, Karolinske Science Park
Fogdevreten 2
171 65 Solna, SE | | Applicant ref. no. | P81803081DK00E | | Inventor | BARNES, Thomas, M., 215 First Street
Suite 400
Cambridge
MA 02142, US,
HOU, Jinzhao, 215 First Street
Suite 400
Cambridge
MA 02142, US,
KING, Bracken, M., 215 First Street
Suite 400
Cambridge
MA 02142, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61P 19/02 (2006.01) , C07K 14/545 (2006.01) | | Title | KIMÆRISKE IL-1-RECEPTORTYPE-I-AGONISTER OG -ANTAGONISTER | | Int. application no. | US2011045995 | | Int. publication no. | WO2012016203 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
